HCV infection: pathogenesis, clinical manifestations and therapy.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Clinical and Experimental Rheumatology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 18570753
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Combination therapy with cyclosporine A and anti-TNF-α agents in the treatment of rheumatoid arthritis and concomitant hepatitis C virus infection

  2007cited by this paper
• Efficacy of low-dose rituximab for mixed cryoglobulinemia.

  2007cited by this paper
• Thyroid Cancer in HCV-Related Chronic Hepatitis Patients: A Case-Control Study

  2007cited by this paper
• Multicenter study on hepatitis C virus-related cryoglobulinemic glomerulonephritis.

  2007cited by this paper
• HCV-related autoimmune and neoplastic disorders: the HCV syndrome.

  2007cited by this paper
• Hepatitis C virus-related lymphoproliferative disorders: an overview.

  2007cited by this paper
• Comparison of anti-agalactosyl IgG antibodies, rheumatoid factors, and anti-cyclic citrullinated peptide antibodies in the differential diagnosis of rheumatoid arthritis and its mimics.

  2007cited by this paper
• Safety of Cyclosporin A in HCV‐Infected Patients

  2007cited by this paper
• Etanercept treatment for three months is safe in patients with rheumatological manifestations associated with hepatitis C virus.

  2007cited by this paper
• B-cells and mixed cryoglobulinemia.

  2007cited by this paper
• Glucose Abnormalities in Patients With Hepatitis C Virus Infection: Epidemiology and Pathogenesis

  2006cited by this paper
• Thyroid Disorders in Chronic Hepatitis C Virus Infection

  2006cited by this paper
• Cyclosporine A for the treatment of autoimmune disorders in HCV infected patients.

  2006cited by this paper
• Interferon-γ-Inducible α-Chemokine CXCL10 Involvement in Graves’ Ophthalmopathy: Modulation by Peroxisome Proliferator-Activated Receptor-γ Agonists

  2006cited by this paper
• Inhibition of TNFα does not induce viral reactivation in patients with chronic hepatitis C infection: two cases

  2006cited by this paper
• Interferon-gamma-inducible alpha-chemokine CXCL10 involvement in Graves' ophthalmopathy: modulation by peroxisome proliferator-activated receptor-gamma agonists.

  2006cited by this paper
• Rituximab treatment for glomerulonephritis in HCV-associated mixed cryoglobulinaemia: efficacy and safety in the absence of steroids.

  2006cited by this paper
• Effect of calcineurin inhibitors on survival and histologic disease severity in HCV‐infected liver transplant recipients

  2006cited by this paper
• Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2.

  2006cited by this paper
• Hepatitis C virus infection: evidence for an association with type 2 diabetes.

  2005influential reference
• Rituximab Therapy for De Novo Mixed Cryoglobulinemia in Renal Transplant Patients

  2005cited by this paper
• Rheumatological manifestations of hepatitis C: incidence in a rheumatology and non-rheumatology setting and the effect of methotrexate and interferon.

  2005influential reference
• Hepatitis C virus and the immune system: a concise review

  2005influential reference
• Difficulties in the differential diagnosis between primitive rheumatic diseases and hepatitis C virus-related disorders.

  2005influential reference
• The tetraspanin web modulates immune-signalling complexes

  2005cited by this paper
• Susceptibility to thyroid disorders in hepatitis C.

  2005cited by this paper
• Management of hepatitis C virus-related arthritis

  2005cited by this paper
• Thyroid disorders in chronic hepatitis C.

  2004influential reference
• Joint sonography in asymptomatic patients with HCV correlated hepatitis.

  2004cited by this paper
• Safety of antitumour necrosis factor (anti-TNF) therapy in patients with chronic viral infections: hepatitis C, hepatitis B, and HIV infection

  2004cited by this paper
• Genetic diversity and evolution of hepatitis C virus--15 years on.

  2004cited by this paper
• Anti-tumor necrosis factor agents for rheumatoid arthritis in the setting of chronic hepatitis C infection.

  2004cited by this paper
• Multiple Viral/Self Immunological Cross-Reactivity in Liver Kidney Microsomal Antibody Positive Hepatitis C Virus-Infected Patients is Associated with the Possession of HLA B51

  2004influential reference
• Thyroid involvement in patients with overt HCV-related mixed cryoglobulinaemia.

  2004influential reference
• Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis.

  2004cited by this paper
• The case for hepatitis C arthritis.

  2004cited by this paper
• Extrahepatic manifestations of hepatitis C infection.

  2003cited by this paper
• Effect of tumour necrosis factor alpha antagonists on serum transaminases and viraemia in patients with rheumatoid arthritis and chronic hepatitis C infection.

  2003cited by this paper
• Hepatitis C virus and arthritis.

  2003cited by this paper
• Hepatitis C virus-related cryoglobulinemic glomerulonephritis: long-term remission after antiviral therapy.

  2003cited by this paper
• Infections and anti–tumor necrosis factor α therapy

  2003cited by this paper
• Infections and anti-tumor necrosis factor alpha therapy.

  2003cited by this paper
• Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon alpha with an anti-CD20.

  2003cited by this paper
• Type 2 diabetes in hepatitis C-related mixed cryoglobulinaemia patients.

  2003cited by this paper
• Efficacy and safety of rituximab in type II mixed cryoglobulinemia.

  2003cited by this paper
• Treatment of chronic hepatitis C infection with cryoglobulinemia

  2002cited by this paper
• Rituximab for the treatment of type II mixed cryoglobulinemia.

  2002cited by this paper
• Course and outcome of hepatitis C

  2002cited by this paper
• Erectile dysfunction and hepatitis C virus infection.

  2002cited by this paper
• Prevalence of non-organ-specific autoantibodies and chronic liver disease in the general population: a nested case-control study of the Dionysos cohort

  1999cited by this paper
• Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C.

  1999cited by this paper
• Rituximab for the treatment of type II mixed cryoglobulinemia.

  1999cited by this paper
• [Extrahepatic manifestations of hepatitis C infection].

  1998cited by this paper
• Binding of hepatitis C virus to CD81.

  1998influential reference
• Clinical manifestations of hepatitis C.

  1997cited by this paper
• Impaired hepatosplenic elimination of circulating cryoglobulins in patients with essential mixed cryoglobulinaemia and hepatitis C virus (HCV) infection.

  1997cited by this paper
• Low hepatitis C viremia levels in patients with anti-liver/kidney microsomal antibody type 1 positive chronic hepatitis.

  1996cited by this paper
• Long-term predictors of survival in essential mixed cryoglobulinemic glomerulonephritis.

  1995cited by this paper
• Interferon therapy in liver/kidney microsomal antibody type 1-positive patients with chronic hepatitis C.

  1994cited by this paper
• LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase.

  1991cited by this paper

• Evaluating the Linkage Between Resistin and Viral Seropositivity in Psoriasis: Evidence from a Tertiary Centre

  2025cites this paper
• Primordial and primary prevention in rheumatological diseases: The time has come.

  2025cites this paper
• Association between hepatitis C virus infection and rheumatoid arthritis: a nationwide cross-sectional study

  2025cites this paper
• Fibroblast Growth Factor 21 in Chronic Hepatitis C: A Potential Non-Invasive Biomarker of Liver Status upon Viral Eradication

  2023cites this paper
• Metabolic disorders induced by PNPLA3 and TM6SF2 gene variants affect chronic kidney disease in patients infected with non-genotype 3 hepatitis C virus

  2023cites this paper
• Impact of direct-acting antiviral regimens on hepatic and extrahepatic manifestations of hepatitis C virus infection

  2022cites this paper
• British Medical Journal Volume 1, No 2., 2021

  2021cites this paper
• MicroRNA-122 As A Potential Biomarker for Liver Injury Resulted from Chronic Hepatitis C Infection

  2021cites this paper
• Hepatocellular Carcinoma Tumor Microenvironment and Its Implications in Terms of Anti-tumor Immunity: Future Perspectives for New Therapeutics

  2021cites this paper
• Autoantibodies and Rheumatologic Manifestations in Hepatitis C Virus Infection

  2021cites this paper
• The role of Th17 cells in viral infections.

  2021cites this paper
• Rheumatologic manifestations of hepatitis C in the era of direct-acting antiviral agents.

  2020cites this paper
• Subclinical hepatitis C virus infection in Egyptian patients with rheumatic diseases: a multi-center study

  2020cites this paper
• Human platelet antigen-3 polymorphism as a risk factor for rheumatological manifestations in hepatitis C

  2020cites this paper
• Treatment of refractory oral lichen planus using direct antiviral agents in a patient with chronic hepatitis C: A case report

  2020cites this paper
• Extra Length Manifestations Of Viral Hepatitis C: Analysis Of Detected Features Of Associated Arthritis And Their Diagnostic Aspects

  2020cites this paper
• Pathophysiology of Hepatitis C and Diabetes Mellitus: Towards the cure of two epidemics in the 21st century

  2019cites this paper
• Study of Association between Celiac Disease and Hepatitis C Infection in Sudanese Patients

  2019cites this paper
• The value of anti‐rods and rings antibodies in Western China population: A retrospective study

  2019cites this paper
• Hepatitis C virus infection impacts work productivity and fatigue: An epidemiologic real-life study.

  2019cites this paper
• Significant HbA1c Lowering in Patients Achieving a Hepatitis C Virus Cure.

  2019cites this paper
• The study of regional peculiarities of parenteral viral hepatitis incidence dynamics among children as an instrument of developing complex regional social programs on the prevention of its increase.

  2019cites this paper
• Artritis víricas

  2019cites this paper
• Genotype-related variations in proinflammatory and regulatory cytokine levels in treated and treatment-naive HCV-infected patients

  2018cites this paper
• Risks of hepatocellular carcinoma and cirrhosis-associated complications in patients with rheumatoid arthritis: a 10-year population-based cohort study in Taiwan

  2018cites this paper
• Arthrites virales

  2018cites this paper
• Recurrent Mixed Cryoglobulinemia Despite Sustained Virologic Response to Treatment: A Case Report.

  2017cites this paper
• Mechanism of Hepatitis C Virus-Induced Diabetes Mellitus.

  2017cites this paper
• Environmental Issues in Thyroid Diseases

  2017cites this paper
• Serum Biomarkers for Discrimination between Hepatitis C-Related Arthropathy and Early Rheumatoid Arthritis

  2017cites this paper
• Autoimmunity in Hepatitis C Virus Infection - An Immunologist's Perspective

  2017cites this paper
• the course of liver injury in patients with concomitant chronic hepatitis c infection and autoimmune hepatitis after treatment with direct acting antiviral agents a case series

  2017cites this paper
• Transcriptional profiling of PBMCs unravels B cell mediated immunopathogenic imprints of HCV vasculitis

  2017cites this paper
• Antiviral Medication in Sexually Transmitted Diseases. Part III: Hepatitis B, Hepatitis C.

  2017cites this paper
• Chemokines in the Pathogenesis and as Therapeutical Markers and Targets of HCV Chronic Infection and HCV Extrahepatic Manifestations.

  2017cites this paper
• Editorial: New Therapies, Markers and Therapeutic Targets in HCV Chronic Infection and HCV Extrahepatic Manifestations.

  2017cites this paper
• Ein positiver ANA/ANCA-Befund – es muss nicht immer eine Kollagenose sein

  2017cites this paper
• Current therapy for chronic hepatitis C: The role of direct-acting antivirals

  2017cites this paper
• Frequency and Etiology of Viral Arthropathies in West African Patients

  2017cites this paper
• Incidence of thyroid disorders in mixed cryoglobulinemia: Results from a longitudinal follow-up.

  2016cites this paper
• Rheumatic Diseases and the Liver

  2016cites this paper
• Viral arthritis.

  2016cites this paper
• The role of human parvovirus B19 and hepatitis C virus in the development of thyroid disorders

  2016cites this paper
• Etiology and Pathogenesis of Hepatocellular Carcinoma: Inflammatory and Toxic Causes

  2016cites this paper
• Rheumatic manifestations of hepatitis C virus chronic infection: Indications for a correct diagnosis.

  2016cites this paper
• Role of CXCL 10 in cryoglobulinaemia

  2015cites this paper
• Chronic hepatitis C virus infection and lymphoproliferative disorders: Mixed cryoglobulinemia syndrome, monoclonal gammopathy of undetermined significance, and B‐cell non‐Hodgkin lymphoma

  2015cites this paper
• Interstitial Lung Disease in Childhood: Clinical and Genetic Aspects

  2015cites this paper
• Hepatitis B virus infection and interferon-inducible protein-10.

  2015cites this paper
• TYPE II MIXED CRYOGLOBULINEMIA IN PATIENTS WITH HEPATITIS C VIRUS: TREATMENT WITH PEGYLATED-INTERFERON AND RIBAVIRIN

  2015cites this paper
• Role of CXCL10 in cryoglobulinemia.

  2015cites this paper
• Anticuerpos anti C1q e infección por el virus de la hepatitis C

  2015cites this paper
• Post-Infectious Arthritis and Reactive Arthritis

  2015cites this paper
• Interleukin-10 level in Occult Hepatitis C Virus Infection in Hemodialysis Patient

  2015cites this paper
• Interferon–ribavirin therapy induces serum antibodies determining ‘rods and rings’ pattern in hepatitis C patients

  2014cites this paper
• Antibody against Distinct Cytoplasmic Antigens in Patients Receiving Anti-Hepatitis C Therapy with Interferon and Ribavirin in Taiwan

  2014cites this paper
• Hepatitis C virus infection and type 1 and type 2 diabetes mellitus.

  2014cites this paper
• Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases.

  2014cites this paper
• Chronic Hepatitis C Virus Infection Is Associated with the Development of Rheumatoid Arthritis: A Nationwide Population-Based Study in Taiwan

  2014cites this paper
• Skin Manifestations and Cryoglobulinemia

  2014cites this paper
• Cytokines and HCV-related autoimmune disorders

  2014influential citation
• Association of oral lichen planus with chronic C hepatitis. Review of the data in literature.

  2014cites this paper
• An update on the management of hepatitis C virus-related arthritis

  2014cites this paper
• Chronic HCV infection and lymphoproliferative disorders: association or causal relationship?

  2014cites this paper
• Autoimmune and Neoplastic Thyroid Diseases Associated with Hepatitis C Chronic Infection

  2014cites this paper
• Hepatitis C-Associated Mixed Cryoglobulinemic Vasculitis Induces Differential Gene Expression in Peripheral Mononuclear Cells

  2014cites this paper
• Thyroid involvement in hepatitis C — Associated mixed cryoglobulinemia

  2014cites this paper
• Hepatitis C virus infection and its rheumatologic implications.

  2014cites this paper
• High Circulating Chemokines (C-X-C Motif) Ligand 9, and (C-X-C Motif) Ligand 11, in Hepatitis C-Associated Cryoglobulinemia

  2013cites this paper
• Parallel increase of circulating CXCL11 and CXCL10 in mixed cryoglobulinemia, while the proinflammatory cytokine IL-6 is associated with high serum Th2 chemokine CCL2

  2013cites this paper
• Challenges in cancer vaccine development for hepatocellular carcinoma.

  2013cites this paper
• Interferon-α, -β and -γ induce CXCL11 secretion in human thyrocytes: modulation by peroxisome proliferator-activated receptor γ agonists.

  2013cites this paper
• Value of IL28B genotyping in patients with HCV‐related mixed cryoglobulinemia: results of a large, prospective study

  2013cites this paper
• HCV-related autoimmune disorders in HCV chronic infection.

  2013cites this paper
• Rheumatic manifestations in hepatitis C virus infection. Case reports

  2013cites this paper
• Occult hepatitis C infection: the prevalence and profile of its immunoregulatory cytokines

  2012cites this paper
• Endocrine Manifestations of HCV-Positive Cryoglobulinemia

  2012cites this paper
• Distinct immunoregulatory cytokine pattern in Egyptian patients with occult Hepatitis C infection and unexplained persistently elevated liver transaminases

  2012cites this paper
• Cytokines and HCV-Related Disorders

  2012cites this paper
• Autoantibodies in patients with chronic hepatitis C virus infection: pitfalls for the diagnosis of rheumatic diseases.

  2012cites this paper
• Occult hepatitis B virus among chronic liver disease patients in Yemen

  2012cites this paper
• Hepatitis C virus in patients with squamous cell carcinoma of the head and neck in Iran: is there any relation?

  2012cites this paper
• Dendritic cells in hepatitis C infection: can they (help) win the battle?

  2011cites this paper
• Peripheral B Cells as Reservoirs for Persistent HCV Infection

  2011cites this paper
• Therapeutic Effects of Korean Red Ginseng Extract in Egyptian Patients with Chronic Liver Diseases

  2011cites this paper
• HCV-related cryoglobulinemic syndrome beginning as isolated gynaecologic vasculitis.

  2011cites this paper
• Distinct cytokine patterns in Occult Hepatitis C and Chronic Hepatitis C Virus Infection

  2011influential citation
• The presence of autoimmune thyroiditis in mixed cryoglobulinemia patients is associated with high levels of circulating interleukin-6, but not of tumor necrosis factor-alpha.

  2011cites this paper
• Autoantibodies to a miRNA-binding protein Argonaute2 (Su antigen) in patients with hepatitis C virus infection.

  2010cites this paper
• Manifestations of chronic hepatitis C virus infection beyond the liver.

  2010cites this paper
• Lichen ruber

  2010cites this paper
• Antiviral treatment including entecavir plus tenofovir disoproxil fumarate for HBV reactivation following a rituximab-based regimen

  2010cites this paper
• Rapid and simple detection of Hepatitis C virus by reverse transcriptase -loop- mediated isothermal amplification method

  2010cites this paper
• Immune signatures in human PBMCs of idiotypic vaccine for HCV-related lymphoproliferative disorders

  2010cites this paper
• High circulating levels of N‐terminal pro‐brain natriuretic peptide and interleukin 6 in patients with mixed cryoglobulinemia

  2010influential citation
• Interstitial lung diseases in children

  2010cites this paper
• Maladies inflammatoires chroniques intestinales et hépatites B et C

  2009cites this paper
• Molekulare Mechanismen der Leberfibrogenese als Grundlage für neue Therapiestrategien der chronischen Hepatitis

  2009cites this paper
• Efficacy and Safety of Anti-TNF-α Therapy Combined with Cyclosporine a in Patients with Rheumatoid Arthritis and Concomitant Hepatitis C Virus Infection

  2009cites this paper
• Treatment strategies for a patient with rheumatoid arthritis and hepatitis C

  2009cites this paper